DOI : 10.1055/s-00034924

Nuklearmedizin - NuclearMedicine

Issue 02 · Volume 58 · March 2019 DOI: 10.1055/s-009-42722

Deutsche Gesellschaft für Nuklearmedizin e.V.
NuklearMedizin 2019
Bremen, 03.–06.04.2019

57. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin

Kongresspräsident: Professor Dr. Michael Schäfers

V1
Hammes, J; Bischof, GN; Bohn, KP; Onur, Ö; Schneider, A; Fliessbach, K; Hönig, M; Jessen, F; Neumaier, B; Drzezga, A; van Eimeren, T: One stop shop: Flortaucipir PET pattern predicts amyloid positivity in neurodegenerative diseases
V2
Unterrainer, M; Fleischmann, DF; Vettermann, F; Ruf, V; Kaiser, L; Nelwan, D; Lindner, S; Brendel, M; Wenter, V; Stöcklein, S; Herms, J; Milenkovic, V; Rupprecht, R; Tonn, JC; Belka, C; Bartenstein, P; Niyazi, M; Albert, NL: TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative 18F-GE-180 PET study
V3
Hönig, M; Bischof, G; Onur, Ö; Kukolja, J; Jessen, F; Fließbach, K; Neumaier, B; Fink, GR; Kalbe, E; Drzezga, A; van Eimeren, T: Level of education modulates the impact of tau-pathology on neuronal function
V4
Beyer, L; Huber, M; Morbelli, S; Unterrainer, M; Chincarini, A; Buffaerts, R; Kramberger, MG; Grmek, M; Garibotto, V; Nicastro, N; Frisoni, GB; Pilotto, A; Garcia-Ptacek, S; Savitcheva, I; Ochoa-Figueroa, MA; Camacho, V; Aarsland, D; Bartenstein, P; Rominger, A; Brendel, M: Striatal dopamine deficiency is associated with increased striatal glucose metabolism in Dementia with Lewy Bodies
V5
Sauerbeck, J; Beyer, L; Schönecker, S; Palleis, C; Höglinger, G; Schuh, E; Rauchmann, B; Rohrer, G; Sonnenfeld, S; Bötzel, K; Danek, A; Rominger, A; Levin, J; Brendel, M: Combined in vivo PET imaging of astrogliosis and tau facilitates differential diagnosis of parkinsonian syndromes in correlation with the phenotype
V6
Barthel, H; Patt, M; Rumpf, JJ; Saur, D; Schroeter, ML; Weise, C; Rullmann, M; Tiepolt, S; Schildan, A; Mishchenko, O; Müller, A; Berndt, M; Koglin, N; Stephens, A; Claßen, J; Sabri, O: Erste Erfahrungen mit der Etablierung von [18F]PI-2620, einem Tau-PET-Tracer der neuen Generation
V7
Hönig, M; Bischof, G; Onur, Ö; Jessen, F; Fließbach, K; Neumaier, B; van Eimeren, T; Drzezga, A: Regional susceptibility of the default mode network is associated with clinical phenotypes of Alzheimer's disease
V8
Blazhenets, G; Sörensen, A; Schiller, F; Frings, L; Meyer, PT: Predictive value of quantitative F-18-Florbetapir and F-18-FDG PET for conversion from MCI to AD